{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T09:24:45Z","timestamp":1793525085847,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2019YJ0044"],"award-info":[{"award-number":["2019YJ0044"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFC2009100"],"award-info":[{"award-number":["2021YFC2009100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFC2009105"],"award-info":[{"award-number":["2021YFC2009105"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The status of vaginal microbiota in persistent high-risk human papilloma virus (HR-HPV) infection is unclear. The present work aimed to identify the vaginal microbiota of persistent HPV infection and explore the possible underlying microbiota factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 100 women were recruited in this study, of which 28 presented HR-HPV persistent infection (P group), 30 showed clearance of any subtype of HR-HPV (C group), and 42 had no history of any HR-HPV infection (NC group). The vaginal microbiota and the community structure of the three groups were compared based on the 16S rRNA sequencing of the V3\u2013V4 region. The microbiota diversity and differential analysis were carried out to detect the potential factors associated with HR-HPV infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      P and C groups showed an increase of Firmicutes and Actinobacteriota but a decrease in Proteobacteria compared to the NC group. The Chao1 index indicated that the microbial richness of the NC group was greater than C group (P\u2009&lt;\u20090.05).The principal co-ordinate analysis(PCoA) revealed differences between the NC and P\/C groups.The linear discriminant analysis effect size (LEfSe) method indicated that Proteobacteria phylum was significantly different in the mean relative abundance in the NC group,but the P and C groups did not show such indicative taxa. The Wilcox rank-sum test indicated that the\n                      <jats:italic>Bifidobacterium<\/jats:italic>\n                      (P\u2009=\u20090.002) and\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      (P\u2009=\u20090.005) of the C group were in a high mean relative abundance compared to the NC group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The persistent HR-HPV infection is associated with dysbiosis of the vaginal microbiota. Microbiome regulation with\n                      <jats:italic>Bifidobacteria<\/jats:italic>\n                      and\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      may affect the clearance of HPV.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-021-03201-w","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T05:05:23Z","timestamp":1641186323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Dysbiosis of vaginal microbiota associated with persistent high-risk human papilloma virus infection"],"prefix":"10.1186","volume":"20","author":[{"given":"Ling","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-2097","authenticated-orcid":false,"given":"Xiaoyu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"3201_CR1","unstructured":"https:\/\/www.who.int\/health-topics\/cervical-cancer#tab=tab_1"},{"issue":"2","key":"3201_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1471-0528.15981","volume":"127","author":"JC Borgogna","year":"2020","unstructured":"Borgogna JC, Shardell MD, Santori EK, Nelson TM, Rath JM, Glover ED, et al. The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis. BJOG. 2020;127(2):182\u201392.","journal-title":"BJOG."},{"issue":"1","key":"3201_CR3","doi-asserted-by":"publisher","first-page":"46.e19","DOI":"10.1016\/j.urolonc.2013.06.012","volume":"32","author":"Y Tolstov","year":"2014","unstructured":"Tolstov Y, Hadaschik B, Pahernik S, Hohenfellner M, Duensing S. Human papillomaviruses in urological malignancies: a critical assessment. Urol Oncol. 2014;32(1):46.e19-46.e27.","journal-title":"Urol Oncol"},{"key":"3201_CR4","first-page":"1","volume":"1110","author":"E Gillet","year":"2011","unstructured":"Gillet E, Meys JF, Verstraelen H, Bosire C, De Sutter P, Temmerman M, et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC Infect Dis. 2011;1110:1.","journal-title":"BMC Infect Dis."},{"issue":"8","key":"3201_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1258\/ijsa.2012.011342","volume":"23","author":"YL Guo","year":"2012","unstructured":"Guo YL, You K, Qiao J, Zhao YM, Geng L. Bacterial vaginosis is conducive to the persistence of HPV infection. Int J STD AIDS. 2012;23(8):581\u20134.","journal-title":"Int J STD AIDS"},{"issue":"10","key":"3201_CR6","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/cam4.496","volume":"4","author":"HJ Vriend","year":"2015","unstructured":"Vriend HJ, Bogaards JA, van Bergen JE, Brink AA, van den Broek IV, Hoebe CJ, et al. Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection. Cancer Med. 2015;4(10):1589\u201398.","journal-title":"Cancer Med"},{"key":"3201_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2334-12-33","volume":"12","author":"MA Clarke","year":"2012","unstructured":"Clarke MA, Rodriguez AC, Gage JC, Herrero R, Hildesheim A, Wacholder S, et al. A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection. BMC Infect Dis. 2012;12:33.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 1","key":"3201_CR8","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011;108(Suppl 1):4680\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3201_CR9","doi-asserted-by":"publisher","first-page":"10200","DOI":"10.1038\/s41598-017-09842-6","volume":"7","author":"M Di Paola","year":"2017","unstructured":"Di Paola M, Sani C, Clemente AM, Iossa A, Perissi E, Castronovo G, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection. Sci Rep. 2017;7(1):10200.","journal-title":"Sci Rep"},{"issue":"11","key":"3201_CR10","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/infdis\/jiu330","volume":"210","author":"RM Brotman","year":"2014","unstructured":"Brotman RM, Shardell MD, Gajer P, Tracy JK, Zenilman JM, Ravel J, et al. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014;210(11):1723\u201333.","journal-title":"J Infect Dis"},{"key":"3201_CR11","doi-asserted-by":"crossref","unstructured":"So KA, Yang EJ, Kim NR, Hong SR, Lee JH, Hwang CS, et al. Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection. PLoS ONE. 2020;15;(9): e0238705.","DOI":"10.1371\/journal.pone.0238705"},{"issue":"2","key":"3201_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/ismej.2010.133","volume":"5","author":"C Lozupone","year":"2011","unstructured":"Lozupone C, Lladser ME, Knights D, Stombaugh J, Knight R. UniFrac: an effective distance metric for microbial community comparison. ISME J. 2011;5(2):169\u201372.","journal-title":"ISME J"},{"key":"3201_CR13","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.","journal-title":"Genome Biol"},{"issue":"3","key":"3201_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/MCO.0000000000000463","volume":"21","author":"M Schwarzer","year":"2018","unstructured":"Schwarzer M. Gut microbiota: puppeteer of the host juvenile growth. Curr Opin Clin Nutr Metab Care. 2018;21(3):179\u201383.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"3201_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40168-016-0203-0","volume":"4","author":"A Mitra","year":"2016","unstructured":"Mitra A, Macintyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 2016;4:58.","journal-title":"Microbiome"},{"key":"3201_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1126\/scitranslmed.3003605","volume":"4","author":"P Gajer","year":"2012","unstructured":"Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UME, Zhong X, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4:132.","journal-title":"Sci Transl Med"},{"key":"3201_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/mi.2015.86","volume":"9","author":"H Borgdorff","year":"2016","unstructured":"Borgdorff H, Gautam R, Armstrong SD, Xia D, Ndayisaba GF, van Teijlingen NH, et al. Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier. Mucosal Immunol. 2016;9:621\u201333.","journal-title":"Mucosal Immunol"},{"key":"3201_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ebiom.2019.04.028","volume":"44","author":"ZE Ilhan","year":"2019","unstructured":"Ilhan ZE, Laniewski P, Thomas N, Roe DJ, Chase DM, Herbst-Kralovetz MM. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. 2019;44:675\u201390.","journal-title":"EBioMedicine"},{"key":"3201_CR19","doi-asserted-by":"publisher","first-page":"587298","DOI":"10.3389\/fpubh.2020.587298","volume":"8","author":"ZT Wei","year":"2021","unstructured":"Wei ZT, Chen HL, Wang CF, Yang GL, Han SM, Zhang SL. Depiction of vaginal microbiota in women with high-risk human papillomavirus infection. Front Public Health. 2021;8:587298.","journal-title":"Front Public Health"},{"issue":"4","key":"3201_CR20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.21037\/atm.2019.12.115","volume":"8","author":"X Chao","year":"2020","unstructured":"Chao X, Sun T, Wang S, Tan X, Fan Q, Shi H, et al. Research of the potential biomarkers in vaginal microbiome for persistent high-risk human papillomavirus infection. Ann Transl Med. 2020;8(4):100.","journal-title":"Ann Transl Med"},{"issue":"4","key":"3201_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/foods11010001","volume":"10","author":"W Lu","year":"2021","unstructured":"Lu W, Fang Z, Liu X, Li L, Zhang P, Zhao J, et al. The potential role of probiotics in protection against influenza virus infection in mice. Foods. 2021;10(4):1\u201316.","journal-title":"Foods"},{"issue":"1","key":"3201_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12602-017-9277-7","volume":"10","author":"KP Fernandez-Duarte","year":"2018","unstructured":"Fernandez-Duarte KP, Olaya-Gal\u00e1n NN, Salas-C\u00e1rdenas SP, Lopez-Rozo J, Gutierrez-Fernandez MF. Bifidobacterium adolescentis (DSM 20083) and Lactobacillus casei (Lafti L26-DSL): Probiotics Able to Block the In Vitro Adherence of Rotavirus in MA104 Cells. Probiotics Antimicrob Proteins. 2018;10(1):56\u201363.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"9","key":"3201_CR23","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s12272-012-0918-9","volume":"35","author":"HM An","year":"2012","unstructured":"An HM, Lee DK, Kim JR, Lee SW, Cha MK, Lee KO, et al. Antiviral activity of Bifidobacterium adolescentis SPM 0214 against herpes simplex virus type 1. Arch Pharm Res. 2012;35(9):1665\u201371.","journal-title":"Arch Pharm Res"},{"issue":"12","key":"3201_CR24","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s12272-013-0141-3","volume":"36","author":"DK Lee","year":"2013","unstructured":"Lee DK, Kang JY, Shin HS, Park IH, Ha NJ. Antiviral activity of Bifidobacterium adolescentis SPM0212 against hepatitis B virus. Arch Pharm Res. 2013;36(12):1525\u201332.","journal-title":"Arch Pharm Res"},{"issue":"4","key":"3201_CR25","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/13102818.2014.945237","volume":"28","author":"MJ Kim","year":"2014","unstructured":"Kim MJ, Lee DK, Park JE, Park IH, Seo JG, Ha NJ. Antiviral activity of Bifidobacterium adolescentis SPM1605 against Coxsackievirus B3. Biotechnol Biotechnol Equip. 2014;28(4):681\u20138.","journal-title":"Biotechnol Biotechnol Equip"},{"issue":"4","key":"3201_CR26","first-page":"601","volume":"17","author":"E Motevaseli","year":"2016","unstructured":"Motevaseli E, Azam R, Akrami SM, Mazlomy M, Saffari M, Modarressi MH, et al. The effect of Lactobacillus crispatus and Lactobacillus rhamnosus culture supernatants on expression of autophagy genes and HPV E6 and E7 oncogenes in the HeLa cell line. Cell J. 2016;17(4):601\u20137.","journal-title":"Cell J"},{"key":"3201_CR27","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2147\/IDR.S210615","volume":"13","author":"Y Li","year":"2020","unstructured":"Li Y, Yu T, Yan H, Li D, Yu T, Yuan T, et al. Vaginal microbiota and HPV infection: novel mechanistic insights and therapeutic strategies. Infect Drug Resist. 2020;13:1213\u201320.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"3201_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12879-017-2938-z","volume":"18","author":"E Palma","year":"2018","unstructured":"Palma E, Recine N, Domenici L, Giorgini M, Pierangeli A, Panici PB. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection. BMC Infect Dis. 2018;18(1):13\u20139.","journal-title":"BMC Infect Dis"},{"issue":"24","key":"3201_CR29","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1016\/j.vaccine.2018.05.009","volume":"36","author":"A Komatsu","year":"2018","unstructured":"Komatsu A, Igimi S, Kawana K. Optimization of human papillomavirus (HPV) type 16 E7-expressing lactobacillus-based vaccine for induction of mucosal E7-specific IFN\u03b3-producing cells. Vaccine. 2018;36(24):3423\u20136.","journal-title":"Vaccine"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-021-03201-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-021-03201-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-021-03201-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T05:21:30Z","timestamp":1641187290000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-021-03201-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3201"],"URL":"https:\/\/doi.org\/10.1186\/s12967-021-03201-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]},"assertion":[{"value":"14 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the Chinese National Code for Health Research Ethics. Ethical approved to conduct this study was obtained from the Ethics Committee in the Sichuan University (NO. 044). Informed consent was obtained from all participants prior to enrolment in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}